U.S. Rep. Robert Aderholt (R-Haleyville) is surprised that a generic abortion drug was approved under the Trump administration.

Earlier this month, the Food and Drug Administration (FDA) approved a generic form of mifepristone, one of the two medications used most to carry out abortions in the U.S.

The FDA said the generic version “therapeutically equivalent” to the brand-name version, Mifeprex, which has been available in the U.S. since 2000.

Aderholt, who is staunchly pro-life, said he hopes the Department of Health and Human Services will reverse that decision.

The congressman discussed this Tuesday on “Washington Watch.”

“Yeah, that was very disappointing. I’ll just be honest with you,” Aderholt said. “Coming out of the Trump administration, of course, this was under the watch of the current Secretary of Health and Human Services that caught us all by surprise. We were not expecting that.”

The pill is made by Evita Solutions, a company that claims on its website that “the medical community in recognizing the utility and freedom that medical abortion provides patients.”

Aderholt said no form of the drug mifepristone should be used ever.

“The drug is not safe, and it is whether it’s generic or whether it’s a non generic drug,” he argued. “This performs an abortion, and it is very dangerous for the mother, and it is just something that I is very puzzling to us, and we’re trying to get the bottom of it.”

Aderholt said he will join other members of Congress in trying and fight against this decision.

“Members of Congress are coming out, right and left in support of us, trying to get the Department of Health and Human Services to pull this back,” he said. “So I don’t know what happened over there at the Department of Health and Human Services, but I this is not something that I think most people who voted for Donald Trump would have expected.”

Yaffee is a contributing writer to Yellowhammer News and hosts “The Yaffee Program” weekdays 9-11 a.m. on WVNN. You can follow him on X @Yaffee.